Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Amortization of Deferred Charges (2022 - 2025)

Historic Amortization of Deferred Charges for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $449000.0.

  • Arcutis Biotherapeutics' Amortization of Deferred Charges fell 4387.5% to $449000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 169.93%. This contributed to the annual value of $5.4 million for FY2024, which is 3409.43% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Amortization of Deferred Charges is $449000.0, which was down 4387.5% from $431000.0 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Amortization of Deferred Charges high stood at $2.6 million for Q4 2024, and its period low was $392000.0 during Q1 2022.
  • For the 4-year period, Arcutis Biotherapeutics' Amortization of Deferred Charges averaged around $889000.0, with its median value being $994000.0 (2023).
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Amortization of Deferred Charges surged by 15541.34% in 2024, and later tumbled by 5866.53% in 2025.
  • Over the past 4 years, Arcutis Biotherapeutics' Amortization of Deferred Charges (Quarter) stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then surged by 155.41% to $2.6 million in 2024, then plummeted by 82.7% to $449000.0 in 2025.
  • Its last three reported values are $449000.0 in Q3 2025, $431000.0 for Q2 2025, and $415000.0 during Q1 2025.